Latest Annual Reports
by Mike Gee
12 June 2026









































AMERISERV FINANCIAL INC /PA/
REVENUE
$88,343,000
4.57%
INCOME
$5,612,000
55.85%
EMPLOYEES
311
CUSTOMERS
N/A
AmeriServ Financial, Inc. is a Pennsylvania bank holding company that owns AmeriServ Bank, a full-service community bank providing retail and commercial banking, trust and wealth management, and investment advisory services focused on central-to-western Pennsylvania.
View Company PageFiled: 2026-03-18
Accelerant Holdings
REVENUE
$912,900,000
51.49%
INCOME
-$1,345,200,000
-5974.24%
EMPLOYEES
862
CUSTOMERS
280
Accelerant operates the Accelerant Risk Exchange, a data-driven marketplace that connects specialty insurance underwriters (MGAs/Members) with insurers, reinsurers, and institutional capital partners, providing harmonized data, analytics, underwriting capacity, and portfolio management.
View Company PageFiled: 2026-03-18
AltEnergy Acquisition Corp
REVENUE
N/A
INCOME
-$2,339,611
13.28%
EMPLOYEES
N/A
CUSTOMERS
N/A
AltEnergy Acquisition Corp. is a SPAC formed in February 2021 that raised proceeds in a 2021 IPO and private warrant placement, holds funds in trust while seeking an initial business combination, and has no operating revenue or customers.
View Company PageFiled: 2026-03-18
AEye, Inc.
REVENUE
N/A
INCOME
-$34,000,000
4.23%
EMPLOYEES
56
CUSTOMERS
N/A
AEye develops and sells software-defined active lidar sensing platforms (Apollo, STRATOS, OPTIS) for automotive autonomy and a range of non-automotive applications, focusing on long-range bistatic lidar, on-chip edge AI, and software-configurable sensing from its R&D headquarters in Pleasanton, California.
View Company PageFiled: 2026-03-18
4D Molecular Therapeutics, Inc.
REVENUE
$85,209,000
230194.59%
INCOME
-$140,109,000
12.90%
EMPLOYEES
196
CUSTOMERS
N/A
4D Molecular Therapeutics is a late-stage biotechnology company developing targeted genetic medicines using its Therapeutic Vector Evolution (TVE) directed-evolution AAV platform to create tissue-specific gene therapies for retinal and pulmonary diseases.
View Company PageFiled: 2026-03-18
Aclarion, Inc.
REVENUE
$75,730
65.62%
INCOME
-$7,233,629
-3.44%
EMPLOYEES
11
CUSTOMERS
3
Aclarion is a healthcare technology company that uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers (via its NOCISCAN/NOCICALC/NOCIGRAM platform) to identify painful intervertebral discs and optimize treatment for discogenic low back pain.
View Company PageFiled: 2026-03-18
Avidbank Holdings, Inc.
REVENUE
$30,929,000
-61.93%
INCOME
-$19,553,000
-193.04%
EMPLOYEES
151
CUSTOMERS
N/A
Avidbank Holdings, Inc. is a San Jose–based bank holding company operating Avidbank, a California state‑chartered commercial bank focused on relationship‑driven commercial banking across Corporate Banking, Commercial Real Estate, Construction, Venture Lending, Specialty Finance and Treasury Management with national venture/specialty coverage.
View Company PageFiled: 2026-03-18
ACTELIS NETWORKS INC
REVENUE
$3,671,000
-52.69%
INCOME
-$8,261,000
-88.87%
EMPLOYEES
N/A
CUSTOMERS
100
Actelis Networks, Inc. is a market leader in cyber-hardened, rapid-deployment hybrid fiber/copper networking solutions for wide-area IoT and government, utilities, rail, telecom, ITS and campus networks, providing devices and secure management software that deliver data and power over existing copper/coax infrastructure.
View Company PageFiled: 2026-03-18
AUBURN NATIONAL BANCORPORATION, INC
REVENUE
$32,793,000
7.17%
INCOME
$7,255,000
13.41%
EMPLOYEES
145
CUSTOMERS
N/A
Auburn National Bancorporation, Inc. is a Delaware-incorporated bank holding company and the parent of AuburnBank, a community bank serving East Alabama with traditional deposit, lending, mortgage and digital banking services through seven branches and a loan production office.
View Company PageFiled: 2026-03-17
ABEONA THERAPEUTICS INC.
REVENUE
$5,820,000
INCOME
$71,183,000
211.69%
EMPLOYEES
226
CUSTOMERS
4
Abeona Therapeutics is a Delaware commercial-stage biopharmaceutical company focused on cell- and gene-therapies, commercializing ZEVASKYN for RDEB and developing AAV-based in‑vivo therapies using AIM™ capsids.
View Company PageFiled: 2026-03-17
Art Technology Acquisition Corp.
REVENUE
N/A
INCOME
-$117,419
EMPLOYEES
3
CUSTOMERS
N/A
A Cayman Islands–incorporated special purpose acquisition company (SPAC) formed to complete an initial business combination targeting technologies, art, financial services and related sectors, completed an IPO in January 2026 and holds a trust of approximately $253,000,000.
View Company PageFiled: 2026-03-17
AN2 Therapeutics, Inc.
REVENUE
N/A
INCOME
-$35,174,000
31.46%
EMPLOYEES
21
CUSTOMERS
N/A
Clinical-stage biopharmaceutical company developing boron-based small-molecule therapeutics across hematology, infectious disease, and oncology, led by epetraborole and AN2-502998.
View Company Page